Evidence map›Paper›PMID 31314969›Full record

ArticleThe New England journal of medicine2019

Health Care Spending, Utilization, and Quality 8 Years into Global Payment.

Zirui Song, Yunan Ji, Dana G Safran, Michael E Chernew

Abstract read
In one paragraph

Article in The New England journal of medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Trends in low-value cancer care during the COVID-19 pandemic.The American journal of managed care · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Zirui SongFrom the Department of Health Care Policy, Harvard Medical School (Z.S., M.E.C.), the Department of Medicine, Massachusetts General Hospital (Z.S.), the Department of Medicine, Tufts University School of Medicine, and Haven (D.G.S.), Boston, and the Graduate School of Arts and Sciences, Harvard University, Cambridge (Y.J.) - all in Massachusetts.ORCID 0000-0002-1042-1162
Yunan JiFrom the Department of Health Care Policy, Harvard Medical School (Z.S., M.E.C.), the Department of Medicine, Massachusetts General Hospital (Z.S.), the Department of Medicine, Tufts University School of Medicine, and Haven (D.G.S.), Boston, and the Graduate School of Arts and Sciences, Harvard University, Cambridge (Y.J.) - all in Massachusetts.
Dana G SafranFrom the Department of Health Care Policy, Harvard Medical School (Z.S., M.E.C.), the Department of Medicine, Massachusetts General Hospital (Z.S.), the Department of Medicine, Tufts University School of Medicine, and Haven (D.G.S.), Boston, and the Graduate School of Arts and Sciences, Harvard University, Cambridge (Y.J.) - all in Massachusetts.
Michael E ChernewFrom the Department of Health Care Policy, Harvard Medical School (Z.S., M.E.C.), the Department of Medicine, Massachusetts General Hospital (Z.S.), the Department of Medicine, Tufts University School of Medicine, and Haven (D.G.S.), Boston, and the Graduate School of Arts and Sciences, Harvard University, Cambridge (Y.J.) - all in Massachusetts.

Funding

Inequities in Health Outcomes in the Twenty-First Century: Understanding New Causes and the Impact of Delivery System Reforms on Health Care DisparitiesDP5OD024564 · OD · HARVARD MEDICAL SCHOOL · PI SONG, ZIRUI · 2017 to 2021
$2.1M
NIH HHS DP5 OD024564NIH Office of the Director undefined Early Independence Award, 1DP5OD024564
6 · The paper itself

Abstract

backgroundPopulation-based global payment gives health care providers a spending target for the care of a defined group of patients. We examined changes in spending, utilization, and quality through 8 years of the Alternative Quality Contract (AQC) of Blue Cross Blue Shield (BCBS) of Massachusetts, a population-based payment model that includes financial rewards and penalties (two-sided risk).

methodsUsing a difference-in-differences method to analyze data from 2006 through 2016, we compared spending among enrollees whose physician organizations entered the AQC starting in 2009 with spending among privately insured enrollees in control states. We examined quantities of sentinel services using an analogous approach. We then compared process and outcome quality measures with averages in New England and the United States.

resultsDuring the 8-year post-intervention period from 2009 to 2016, the increase in the average annual medical spending on claims for the enrollees in organizations that entered the AQC in 2009 was $461 lower per enrollee than spending in the control states (P<0.001), an 11.7% relative savings on claims. Savings on claims were driven in the early years by lower prices and in the later years by lower utilization of services, including use of laboratory testing, certain imaging tests, and emergency department visits. Most quality measures of processes and outcomes improved more in the AQC cohorts than they did in New England and the nation in unadjusted analyses. Savings were generally larger among subpopulations that were enrolled longer. Enrollees of organizations that entered the AQC in 2010, 2011, and 2012 had medical claims savings of 11.9%, 6.9%, and 2.3%, respectively, by 2016. The savings for the 2012 cohort were statistically less precise than those for the other cohorts. In the later years of the initial AQC cohorts and across the years of the later-entry cohorts, the savings on claims exceeded incentive payments, which included quality bonuses and providers' share of the savings below spending targets.

conclusionsDuring the first 8 years after its introduction, the BCBS population-based payment model was associated with slower growth in medical spending on claims, resulting in savings that over time began to exceed incentive payments. Unadjusted measures of quality under this model were higher than or similar to average regional and national quality measures. (Funded by the National Institutes of Health.).

Indexed as

Blue Cross Blue Shield Insurance PlansQuality of Health CareHealth ExpendituresMassachusettsReferral and ConsultationReimbursement, IncentiveReimbursement MechanismsUnited States

Identifiers

PMID31314969
PMCPMC6733755

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.